177 related articles for article (PubMed ID: 26424402)
1. Targeting Receptor Tyrosine Kinases Using Monoclonal Antibodies: The Most Specific Tools for Targeted-Based Cancer Therapy.
Shabani M; Hojjat-Farsangi M
Curr Drug Targets; 2016; 17(14):1687-1703. PubMed ID: 26424402
[TBL] [Abstract][Full Text] [Related]
2. Eph receptors as cancer targets for antibody-based therapy.
Tang FHF; Davis D; Arap W; Pasqualini R; Staquicini FI
Adv Cancer Res; 2020; 147():303-317. PubMed ID: 32593404
[TBL] [Abstract][Full Text] [Related]
3. New targeted therapies for gastric cancer.
Asaoka Y; Ikenoue T; Koike K
Expert Opin Investig Drugs; 2011 May; 20(5):595-604. PubMed ID: 21406037
[TBL] [Abstract][Full Text] [Related]
4. Roles for receptor tyrosine kinases in tumor progression and implications for cancer treatment.
Ghosh S; Marrocco I; Yarden Y
Adv Cancer Res; 2020; 147():1-57. PubMed ID: 32593398
[TBL] [Abstract][Full Text] [Related]
5. The scatter factor signaling pathways as therapeutic associated target in cancer treatment.
Accornero P; Pavone LM; Baratta M
Curr Med Chem; 2010; 17(25):2699-712. PubMed ID: 20586722
[TBL] [Abstract][Full Text] [Related]
6. Emerging Receptor Tyrosine Kinase Drug Targets: Implications for Antibody-Based Therapies for Oncology and Immunologic Disorders.
LaVallee TM; Alvarado D; Garton AJ; Trombetta ES; Gedrich R; McMahon G
Crit Rev Oncog; 2015; 20(5-6):485-508. PubMed ID: 27279243
[TBL] [Abstract][Full Text] [Related]
7. Antibodies directed against receptor tyrosine kinases: current and future strategies to fight cancer.
Fauvel B; Yasri A
MAbs; 2014; 6(4):838-51. PubMed ID: 24859229
[TBL] [Abstract][Full Text] [Related]
8. The receptor tyrosine kinase ROR1--an oncofetal antigen for targeted cancer therapy.
Hojjat-Farsangi M; Moshfegh A; Daneshmanesh AH; Khan AS; Mikaelsson E; Osterborg A; Mellstedt H
Semin Cancer Biol; 2014 Dec; 29():21-31. PubMed ID: 25068995
[TBL] [Abstract][Full Text] [Related]
9. Receptor Tyrosine Kinase-Targeted Cancer Therapy.
Yamaoka T; Kusumoto S; Ando K; Ohba M; Ohmori T
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30404198
[TBL] [Abstract][Full Text] [Related]
10. The use of protein array to identify targetable receptor tyrosine kinases for treatment of human colon cancer.
Morishita A; Gong J; Nomura T; Yoshida H; Izuishi K; Suzuki Y; Kushida Y; Haba R; D'Armiento J; Masaki T
Int J Oncol; 2010 Oct; 37(4):829-35. PubMed ID: 20811704
[TBL] [Abstract][Full Text] [Related]
11. Targeting non-receptor tyrosine kinases using small molecule inhibitors: an overview of recent advances.
Hojjat-Farsangi M
J Drug Target; 2016; 24(3):192-211. PubMed ID: 26211367
[TBL] [Abstract][Full Text] [Related]
12. Receptor tyrosine kinases as target for anti-cancer therapy.
Brunelleschi S; Penengo L; Santoro MM; Gaudino G
Curr Pharm Des; 2002; 8(22):1959-72. PubMed ID: 12171522
[TBL] [Abstract][Full Text] [Related]
13. Targeting epidermal growth factor receptor in solid tumors: critical evaluation of the biological importance of therapeutic monoclonal antibodies.
Gialeli Ch; Kletsas D; Mavroudis D; Kalofonos HP; Tzanakakis GN; Karamanos NK
Curr Med Chem; 2009; 16(29):3797-804. PubMed ID: 19747140
[TBL] [Abstract][Full Text] [Related]
14. Spatial regulation of receptor tyrosine kinases in development and cancer.
Casaletto JB; McClatchey AI
Nat Rev Cancer; 2012 May; 12(6):387-400. PubMed ID: 22622641
[TBL] [Abstract][Full Text] [Related]
15. TetraMabs: simultaneous targeting of four oncogenic receptor tyrosine kinases for tumor growth inhibition in heterogeneous tumor cell populations.
Castoldi R; Schanzer J; Panke C; Jucknischke U; Neubert NJ; Croasdale R; Scheuer W; Auer J; Klein C; Niederfellner G; Kobold S; Sustmann C
Protein Eng Des Sel; 2016 Oct; 29(10):467-475. PubMed ID: 27578890
[TBL] [Abstract][Full Text] [Related]
16. Oligonucleotide aptamers against tyrosine kinase receptors: Prospect for anticancer applications.
Camorani S; Crescenzi E; Fedele M; Cerchia L
Biochim Biophys Acta Rev Cancer; 2018 Apr; 1869(2):263-277. PubMed ID: 29574128
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic Antibodies in Cancer Therapy.
Gasser M; Waaga-Gasser AM
Adv Exp Med Biol; 2016; 917():95-120. PubMed ID: 27236554
[TBL] [Abstract][Full Text] [Related]
18. Receptor tyrosine kinase inhibitors in thyroid cancer.
Castellone MD; Carlomagno F; Salvatore G; Santoro M
Best Pract Res Clin Endocrinol Metab; 2008 Dec; 22(6):1023-38. PubMed ID: 19041829
[TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor receptor targeting in cancer: a review of trends and strategies.
Yewale C; Baradia D; Vhora I; Patil S; Misra A
Biomaterials; 2013 Nov; 34(34):8690-707. PubMed ID: 23953842
[TBL] [Abstract][Full Text] [Related]
20. Primary breast cancer cell culture yields intra-tumor heterogeneous subpopulations expressing exclusive patterns of receptor tyrosine kinases.
Esparza-López J; Ramos-Elías PA; Castro-Sánchez A; Rocha-Zavaleta L; Escobar-Arriaga E; Zentella-Dehesa A; León-Rodríguez E; Medina-Franco H; Ibarra-Sánchez Mde J
BMC Cancer; 2016 Sep; 16(1):740. PubMed ID: 27645148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
